TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30

M Gerlach, S Schmitt, P Cyprys,M-A Kasper, I Mai,MH Vermeer, SM Horwitz, G Fingerle-Rowson,A Vogl,D Schumacher, J Helma-Smets

European Journal of Cancer（2022）

Cited 0|Views8

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined